You have 9 free searches left this month | for more free features.

Condition

Unresectable, Recurrent or Metastatic Melanoma (1)

Untreated Mucosal or Acral Lentiginous Melanoma (1)

Overall Status

Terminated (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Zai Lab (Shanghai) Co., Ltd. (1)

Collaborator

Intervention

mgd013 (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

mgd013

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Unresectable, Recurrent or Metastatic Melanoma, Untreated Mucosal or Acral Lentiginous Melanoma Trial in China (MGD013)

Terminated

Unresectable, Recurrent or Metastatic Melanoma
Untreated Mucosal or Acral Lentiginous Melanoma

MGD013

Beijing, Beijing, China
+12 more

Apr 12, 2022